List of Excipients in API scopolamine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing scopolamine
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | TRANSDERM SCOP | scopolamine | 0067-4346 | LIGHT MINERAL OIL | |
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | TRANSDERM SCOP | scopolamine | 0067-4346 | POLYISOBUTYLENE | |
Baxter Healthcare Corporation | TRANSDERM SCOP | scopolamine | 10019-553 | LIGHT MINERAL OIL | |
Baxter Healthcare Corporation | TRANSDERM SCOP | scopolamine | 10019-553 | POLYISOBUTYLENE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing scopolamine
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 | COPOVIDONE K25-31 |
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 | D&C BLACK NO. 2 |
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 | DIMETHICONE |
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 | DOCUSATE SODIUM |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for scopolamine
Excipient focus: CHLOROFORM
scopolamine drug variants containing CHLOROFORM
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | scopolamine | 54868-2803 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing CHLOROFORM
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
>Company | >Ingredient | >NDC |
Excipient focus: CINQUASIA RED
scopolamine drug variants containing CINQUASIA RED
Company | Ingredient | NDC |
---|---|---|
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing CINQUASIA RED
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
>Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
scopolamine drug variants containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
A-S Medication Solutions | scopolamine | 50090-5349 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C BLACK NO. 2
scopolamine drug variants containing D&C BLACK NO. 2
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
A-S Medication Solutions | scopolamine | 50090-5349 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing D&C BLACK NO. 2
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Physicians Total Care Inc | scopolamine | 54868-2803 |
>Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
scopolamine drug variants containing DIMETHICONE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
A-S Medication Solutions | scopolamine | 50090-5349 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing DIMETHICONE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
Excipient focus: DOCUSATE SODIUM
scopolamine drug variants containing DOCUSATE SODIUM
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
A-S Medication Solutions | scopolamine | 50090-5349 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing DOCUSATE SODIUM
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
Excipient focus: ETHYL ACETATE
scopolamine drug variants containing ETHYL ACETATE
Company | Ingredient | NDC |
---|---|---|
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing ETHYL ACETATE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
scopolamine drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
scopolamine drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
A-S Medication Solutions | scopolamine | 50090-5349 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
scopolamine drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
A-S Medication Solutions | scopolamine | 50090-5349 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL MYRISTATE
scopolamine drug variants containing ISOPROPYL MYRISTATE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | scopolamine | 0591-2258 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing ISOPROPYL MYRISTATE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
A-S Medication Solutions | scopolamine | 50090-5349 |
>Company | >Ingredient | >NDC |
Excipient focus: LIGHT MINERAL OIL
scopolamine drug variants containing LIGHT MINERAL OIL
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Physicians Total Care Inc | scopolamine | 54868-2803 |
Sandoz Inc | scopolamine | 66758-208 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing LIGHT MINERAL OIL
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
A-S Medication Solutions | scopolamine | 50090-5349 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
Excipient focus: OLEYL ALCOHOL
scopolamine drug variants containing OLEYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | scopolamine | 0591-2258 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing OLEYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
A-S Medication Solutions | scopolamine | 50090-5349 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYISOBUTYLENE
scopolamine drug variants containing POLYISOBUTYLENE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Physicians Total Care Inc | scopolamine | 54868-2803 |
Sandoz Inc | scopolamine | 66758-208 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing POLYISOBUTYLENE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
A-S Medication Solutions | scopolamine | 50090-5349 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYTETRAFLUOROETHYLENE
scopolamine drug variants containing POLYTETRAFLUOROETHYLENE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
A-S Medication Solutions | scopolamine | 50090-5349 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing POLYTETRAFLUOROETHYLENE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Physicians Total Care Inc | scopolamine | 54868-2803 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
scopolamine drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
A-S Medication Solutions | scopolamine | 50090-5349 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
scopolamine drug variants containing TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
A-S Medication Solutions | scopolamine | 50090-5349 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
Excipient focus: TROLAMINE
scopolamine drug variants containing TROLAMINE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | scopolamine | 0378-6470 |
A-S Medication Solutions | scopolamine | 50090-5349 |
>Company | >Ingredient | >NDC |
scopolamine drug variants not containing TROLAMINE
Company | Ingredient | NDC |
---|---|---|
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | scopolamine | 0067-4346 |
Actavis Pharma Inc | scopolamine | 0591-2258 |
Baxter Healthcare Corporation | scopolamine | 10019-553 |
Ingenus Pharmaceuticals LLC | scopolamine | 50742-505 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.